Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Miami Beach, Florida Clinical Trials

A listing of Miami Beach, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (7) clinical trials

Combination Pembrolizumab Chemotherapy and Bevacizumab in Patients With Cervical Cancer

This is a single arm, open-label, phase II study to assess progression free survival in patients treated with pembrolizumab, chemotherapy, and bevacizumab for recurrent, persistent, or metastatic cervical cancer. Progression free survival will be assessed in patients treated with this combination. Eligible patients will require tissue biopsy for diagnostic confirmation ...

Phase

4.56 miles

Learn More »

Study of LN-145 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

LN-145 is an adoptive cell transfer therapy that utilizes an autologous TIL manufacturing process, as originally developed by the NCI, for the treatment of patients with recurrent, metastatic, or persistent cervical carcinoma. The cell transfer therapy used in this study involves patients receiving a NMA lymphocyte depleting preparative regimen, followed ...

Phase

4.56 miles

Learn More »

Pembrolizumab Paclitaxel and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).

This is a single arm, open-label, phase II study to assess pathologic objective response rate (complete response + partial response) in patients treated with pembrolizumab, paclitaxel and carboplatin for advanced stage III or IV Ovarian, Fallopian Tube, or Peritoneal Carcinoma (EOC). Eligible patients will undergo tissue biopsies to confirm diagnosis, ...

Phase

4.56 miles

Learn More »

Multi-epitope Folate Receptor Alpha Peptide Vaccine GM-CSF and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

PRIMARY OBJECTIVES: I. To show that multi-epitope folate receptor alpha peptide vaccine (folate receptor [FR]alpha peptide vaccine) with sargramostim (GM-CSF) adjuvant will prolong the disease-free survival (DFS) compared to GM-CSF adjuvant treatment in patients with triple negative breast cancer. SECONDARY OBJECTIVES: I. To compare the safety and tolerability of metronomic ...

Phase

4.56 miles

Learn More »

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain

To evaluate the efficacy of three doses of quinagolide administered as an extended-release vaginal ring compared to placebo on reduction of moderate to severe endometriosis-related pain

Phase

5.88 miles

Learn More »

Safety Tolerability and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)

This study will evaluate the safety, tolerability, and efficacy of Human Cytomegalovirus (CMV) vaccine V160 administered in a 2-dose or 3-dose regimen in healthy seronegative women 16 to 35 years of age. Participants will receive blinded V160 on Day 1, Month 2, and Month 6 (3-dose regimen), V160 on Day ...

Phase

8.35 miles

Learn More »

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

This is a Phase 2, multicenter, double-blind (sponsor-unblinded), randomized, placebo-controlled study to assess the safety and efficacy of Elagolix in women with polycystic ovary syndrome (PCOS). PCOS is one of the most common hormonal disorders in women of reproductive age, yet few treatment options are available. This study will help ...

Phase

9.57 miles

Learn More »